Bevacizumab in combination with chemotherapy for second-line treatment of HER2-n...
Prof Adam Brufsky - University of Pittsburgh Cancer Institute, USA
Bevacizumab in combination with chemotherapy for second-line treatment of HER2-negative metastatic breast cancer ( Prof Adam Brufsky - University of Pittsburgh Cancer Institute, USA )
28 Jan 2010
Bevacizumab plus docetaxel compared with placebo plus docetaxel for locally recu...
Dr David Miles - Mount Vernon Hospital, United Kingdom
Bevacizumab plus docetaxel compared with placebo plus docetaxel for locally recurrent or metastatic breast cancer ( Dr David Miles - Mount Vernon Hospital, United Kingdom )
28 Jan 2010
Exemestane vs tamoxifen followed by exemestane
Dr Daniel Rea - University of Birmingham, UK
Exemestane vs tamoxifen followed by exemestane ( Dr Daniel Rea - University of Birmingham, UK )
28 Jan 2010
Using biology of tumours to predict effective therapies
Dr Laura Van`t Veer - The Netherlands Cancer Institute, Amsterdam, The Netherlan...
Using biology of tumours to predict effective therapies ( Dr Laura Van`t Veer - The Netherlands Cancer Institute, Amsterdam, The Netherlands )
27 Jan 2010
Translation of endocrine systemic treatment
Prof Giuseppe Viale - European Institute of Oncology, Milan, Italy
Translation of endocrine systemic treatment ( Prof Giuseppe Viale - European Institute of Oncology, Milan, Italy )
27 Jan 2010
New paradigms in tumour immunotherapy
Dr Tyler Curiel - University of Texas Health Science Center, San Antonio, USA
New paradigms in tumour immunotherapy ( Dr Tyler Curiel - University of Texas Health Science Center, San Antonio, USA )
27 Jan 2010
Early breast cancer trials
Prof Sarah Darby - Clinical Trial Service Unit, Oxford University, UK
Early breast cancer trials ( Prof Sarah Darby - Clinical Trial Service Unit, Oxford University, UK )
27 Jan 2010
Causes and prevention of breast cancer
Dr Valerie Beral - University of Oxford, UK
Causes and prevention of breast cancer ( Dr Valerie Beral - University of Oxford, UK )
27 Jan 2010
Applying new proteomic technologies to improve patient management
Dr Gordon Mills - University of Texas MD Anderson Cancer Center, Houston, USA
Applying new proteomic technologies to improve patient management ( Dr Gordon Mills - University of Texas MD Anderson Cancer Center, Houston, USA )
27 Jan 2010
Sentinel lymph node biopsy
Prof Quentin Pankhurst and Dr Michael Douek - University College London, UK
Sentinel lymph node biopsy ( Prof Quentin Pankhurst and Dr Michael Douek - University College London, UK )
27 Jan 2010
Fulvestrant as treatment for advanced breast cancer
Dr Angelo Di Leo - Sandro Pitigliani Medical Oncology Unit, Prato Hospital, Ital...
Fulvestrant as treatment for advanced breast cancer ( Dr Angelo Di Leo - Sandro Pitigliani Medical Oncology Unit, Prato Hospital, Italy )
27 Jan 2010
How life style factors effect survival of breast cancer patients
Prof Michelle Holmes - Harvard Medical School, USA
How life style factors effect survival of breast cancer patients ( Prof Michelle Holmes - Harvard Medical School, USA )
27 Jan 2010